Free Trial

Eli Lilly and Company (LLY) 10K Form and Latest SEC Filings 2026

Eli Lilly and Company logo
$958.05 -16.91 (-1.73%)
As of 01:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Eli Lilly and Company SEC Filings & Recent Activity

Eli Lilly and Company (NYSE:LLY) has submitted 1,249+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Eli Lilly and Company's financial statements. The most recent filing was a Form 424B2 submitted on May 8, 2026.

Form 4
ELI LILLY & Co Reports Ownership Change on Apr. 21, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Eli Lilly and Company Files Current Report on May. 7, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Eli Lilly and Company Files Quarterly Report on Apr. 30, 2026

The 10-Q contains Eli Lilly and Company's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Eli Lilly and Company SEC Filing History

Browse Eli Lilly and Company's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/08/2026 5:05 AM
Eli Lilly and Company (59478) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
05/07/2026 3:41 PM
Eli Lilly and Company (59478) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 4:25 PM
Eli Lilly and Company (59478) Subject
Form FWP
05/06/2026 3:35 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2026 7:04 AM
Eli Lilly and Company (59478) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
04/30/2026 10:25 AM
Eli Lilly and Company (59478) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2026 6:03 AM
Eli Lilly and Company (59478) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2026 12:18 PM
Eli Lilly and Company (59478) Subject
Friends Fiduciary Corp (1696940) Filed by
Form PX14A6G
04/21/2026 3:14 PM
Alvarez Ralph (1310215) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2026 3:16 PM
Eli Lilly and Company (59478) Issuer
Fyrwald J Erik (1343564) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2026 3:18 PM
Eli Lilly and Company (59478) Issuer
LUCIANO JUAN R (1455792) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2026 3:20 PM
Eli Lilly and Company (59478) Issuer
Sulzberger Gabrielle (1262388) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2026 2:25 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Filed by
Form SCHEDULE 13G/A
03/31/2026 7:18 AM
Centessa Pharmaceuticals plc (1847903) Subject
Eli Lilly and Company (59478) Filed by
Form DFAN14A
03/26/2026 5:02 PM
Eli Lilly and Company (59478) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/20/2026 3:23 PM
Eli Lilly and Company (59478) Filer
Form DEFA14A
03/17/2026 3:29 PM
Alvarez Ralph (1310215) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 3:30 PM
Eli Lilly and Company (59478) Issuer
Fyrwald J Erik (1343564) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:35 PM
Eli Lilly and Company (59478) Filer
Form PRE 14A
02/19/2026 3:18 PM
Dozier Eric (1955972) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 3:22 PM
Eli Lilly and Company (59478) Issuer
Rau Diogo (1860253) Reporting
Form 4/A
02/12/2026 12:58 PM
Eli Lilly and Company (59478) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/11/2026 3:14 PM
Custer Kenneth L. (2071542) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2026 3:16 PM
Dozier Eric (1955972) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2026 3:17 PM
Eli Lilly and Company (59478) Issuer
Hakim Anat (1685556) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2026 3:17 PM
Eli Lilly and Company (59478) Issuer
Hernandez Edgardo (1861052) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2026 3:19 PM
Eli Lilly and Company (59478) Issuer
Jonsson Patrik (1786054) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2026 3:20 PM
Eli Lilly and Company (59478) Issuer
Montarce Lucas (1752447) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2026 3:22 PM
Eli Lilly and Company (59478) Issuer
Rau Diogo (1860253) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2026 6:05 AM
Eli Lilly and Company (59478) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 8:27 AM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Filed by
Form SCHEDULE 13G/A
01/21/2026 3:25 PM
Eli Lilly and Company (59478) Issuer
LUCIANO JUAN R (1455792) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2026 3:27 PM
Eli Lilly and Company (59478) Issuer
Sulzberger Gabrielle (1262388) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2026 5:01 AM
Aktis Oncology, Inc. (2035832) Issuer
Eli Lilly and Company (59478) Reporting
Form 3
Initial statement of beneficial ownership of securities  
01/15/2026 5:02 AM
Aktis Oncology, Inc. (2035832) Subject
Eli Lilly and Company (59478) Filed by
Form SCHEDULE 13D
12/23/2025 11:52 AM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2025 3:41 PM
Alvarez Ralph (1310215) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 3:42 PM
Eli Lilly and Company (59478) Issuer
Fyrwald J Erik (1343564) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 3:43 PM
Eli Lilly and Company (59478) Issuer
Hedley Mary Lynne (1340823) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 3:45 PM
Eli Lilly and Company (59478) Issuer
LUCIANO JUAN R (1455792) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 3:46 PM
Eli Lilly and Company (59478) Issuer
Sulzberger Gabrielle (1262388) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2025 7:46 AM
Adverum Biotechnologies, Inc. (1501756) Subject
Eli Lilly and Company (59478) Filed by
Form SC TO-T/A
12/08/2025 3:10 PM
Bertozzi Carolyn R (1698766) Reporting
Eli Lilly and Company (59478) Issuer
Form 3
Initial statement of beneficial ownership of securities  
11/24/2025 2:01 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2025 3:19 PM
Eli Lilly and Company (59478) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 2:05 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2025 3:39 PM
Eli Lilly and Company (59478) Issuer
JOHNSON KIMBERLY H (1658089) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2025 3:25 PM
Eli Lilly and Company (59478) Issuer
Moeller Jon R (1450613) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2025 3:26 PM
Eli Lilly and Company (59478) Issuer
Sulzberger Gabrielle (1262388) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2025 3:17 PM
Eli Lilly and Company (59478) Issuer
Hedley Mary Lynne (1340823) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2025 3:19 PM
Eli Lilly and Company (59478) Issuer
JACKSON JAMERE (1601813) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2025 3:21 PM
Eli Lilly and Company (59478) Issuer
Kaelin William G Jr (1551715) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2025 3:12 PM
Alvarez Ralph (1310215) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 2:02 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2025 2:15 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/10/2025 5:00 PM
Eli Lilly and Company (59478) Issuer
Skovronsky Daniel (1741474) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2025 5:01 PM
Eli Lilly and Company (59478) Issuer
Ricks David A (1538604) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2025 2:11 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2025 2:05 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/03/2025 2:06 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2025 4:34 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Filed by
Form SCHEDULE 13G/A
10/30/2025 1:54 PM
Eli Lilly and Company (59478) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
10/30/2025 10:15 AM
Eli Lilly and Company (59478) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2025 6:03 AM
Eli Lilly and Company (59478) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2025 3:30 PM
Adverum Biotechnologies, Inc. (1501756) Subject
Eli Lilly and Company (59478) Filed by
Form SC TO-C
10/22/2025 3:17 PM
Alvarez Ralph (1310215) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2025 3:19 PM
Eli Lilly and Company (59478) Issuer
Fyrwald J Erik (1343564) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2025 3:22 PM
Eli Lilly and Company (59478) Issuer
Hedley Mary Lynne (1340823) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2025 3:24 PM
Eli Lilly and Company (59478) Issuer
LUCIANO JUAN R (1455792) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2025 3:24 PM
Eli Lilly and Company (59478) Issuer
Sulzberger Gabrielle (1262388) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2025 1:57 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2025 2:35 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 2:20 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2025 3:08 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2025 3:00 PM
Eli Lilly and Company (59478) Issuer
LILLY ENDOWMENT INC (316011) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2025 2:04 PM
Eli Lilly and Company (59478) Subject
LILLY ENDOWMENT INC (316011) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2025 3:45 PM
Alvarez Ralph (1310215) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 3:47 PM
Eli Lilly and Company (59478) Issuer
Fyrwald J Erik (1343564) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 3:48 PM
Eli Lilly and Company (59478) Issuer
Hedley Mary Lynne (1340823) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 3:49 PM
Eli Lilly and Company (59478) Issuer
LUCIANO JUAN R (1455792) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 3:49 PM
Eli Lilly and Company (59478) Issuer
Sulzberger Gabrielle (1262388) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2025 3:15 PM
Custer Kenneth L. (2071542) Reporting
Eli Lilly and Company (59478) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2025 3:19 PM
Eli Lilly and Company (59478) Subject
Zakrowski Donald A (1561539) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2025 3:14 PM
Eli Lilly and Company (59478) Issuer
Zakrowski Donald A (1561539) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025 3:16 PM
Eli Lilly and Company (59478) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2025 4:17 PM
Eli Lilly and Company (59478) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
08/18/2025 4:28 PM
Eli Lilly and Company (59478) Subject
Form FWP
08/18/2025 7:34 AM
Eli Lilly and Company (59478) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
08/12/2025 3:20 PM
Eli Lilly and Company (59478) Issuer
Skovronsky Daniel (1741474) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Eli Lilly and Company SEC Filings - Frequently Asked Questions

Eli Lilly and Company (LLY) has submitted 1,249+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Eli Lilly and Company's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Eli Lilly and Company's financial statements page.

The most recent filing was a Form 424B2 submitted on May 8, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:LLY) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners